The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Place navigation impaired in rats with hippocampal lesions
Morris, R. G. M., Garrud, P., Rawlins, J. N. P., & O'Keefe, J. (1982) · Nature · doi:10.1038/297681a0 · Cited by 6,340
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Skalli, O., Ropraz, P., Trzeciak, A., Benzonana, G., Gillessen, D., & Gabbiani, G. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.6.2787 · Cited by 1,621
Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,465
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain
Colton, C. A. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9164-4 · Cited by 877
Biochemical and functional characterization of three activated macrophage populations
Edwards, J. P., Zhang, X., Frauwirth, K. A., & Mosser, D. M. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0406249 · Cited by 863
Inflammatory processes in Alzheimer's disease
Heneka, M. T., & O'Banion, M. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.017 · Cited by 782
Lee, J. W., Lee, Y. K., Yuk, D. Y., Choi, D. Y., Ban, S. B., Oh, K. W., & Hong, J. T. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-37 · Cited by 772
Self-citationLeissring, M. A., Farris, W., Chang, A. Y., Walsh, D. M., Wu, X., Sun, X., Frosch, M. P., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00787-6 · Cited by 719
CD36 Mediates the Innate Host Response to β-Amyloid
El Khoury, J. B., Moore, K. J., Means, T. K., Leung, J., Terada, K., Toft, M., Freeman, M. W., & Luster, A. D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021546 · Cited by 483
Koenigsknecht-Talboo, J., & Landreth, G. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1808-05.2005 · Cited by 477
Lee, C. G., Hartl, D., Lee, G. R., Koller, B., Matsuura, H., Da Silva, C. A., Sohn, M. H., Cohn, L., Homer, R. J., Kozhich, A. A., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081271 · Cited by 434
Coraci, I. S., Husemann, J., Berman, J. W., Hulette, C., Dufour, J. H., Campanella, G. K., Luster, A. D., Silverstein, S. C., & El Khoury, J. B. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64354-4 · Cited by 398 · cited 1×
“Studies performed in transgenic animals suggest that neuroinflammation plays an important role in the process of cerebral amyloid deposition (Coraci et al., 2002; Lee et al., 2008).”
BackgroundPonomarev, E. D., Maresz, K., Tan, Y., & Dittel, B. N. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1922-07.2007 · Cited by 396 · cited 1×
“The aggregated A protein, which is present in senile plaques of AD patients, activates microglia to produce neurotoxic substances that contribute to the neurodegenerative changes (Ponomarev et al., 2007).”
BackgroundSchindowski, K., Bretteville, A., Leroy, K., Bégard, S., Brion, J.-P., Hamdane, M., & Buée, L. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.060002 · Cited by 395
Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD.
(2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-27 · Cited by 393
He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., & Shen, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200705042 · Cited by 390
Butovsky, O., Koronyo-Hamaoui, M., Kunis, G., Ophir, E., Landa, G., Cohen, H., & Schwartz, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604681103 · Cited by 388
Ohtaki, H., Ylostalo, J. H., Foraker, J. E., Robinson, A. P., Reger, R. L., Shioda, S., & Prockop, D. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803670105 · Cited by 387
Jimenez, S., Baglietto-Vargas, D., Caballero, C., Moreno-Gonzalez, I., Torres, M., Sanchez-Varo, R., Ruano, D., Vizuete, M., Gutierrez, A., & Vitorica, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3024-08.2008 · Cited by 383 · cited 1×
“One study observed the exisence of an age-dependant phenotypic change of microglial ctivation in the hippocampus of an AD mouse model, from n alternative (expressing IL-4) activation state to a classic ytotoxic (expressing IL-1 and TNF- ) phenotype (Jimenez et al., 2008).”
BackgroundVendrame, M., Cassady, J., Newcomb, J., Butler, T., Pennypacker, K. R., Zigova, T., Davis Sanberg, C., Sanberg, P. R., & Willing, A. E. (2004) · Stroke · doi:10.1161/01.str.0000141681.06735.9b · Cited by 383
Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ
Yan, P., Hu, X., Song, H., Yin, K., Bateman, R. J., Cirrito, J. R., Xiao, Q., Hsu, F. F., Turk, J. W., Xu, J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602440200 · Cited by 380 · cited 1×
“Microglia secrete proteolytic enzymes that degrade A , such as IDE (insulin-degrading enzyme), NEP (neprilysin), MMP-9 (matrix metalloproteinase 9), and plasminogen (Leissring et al., 2003; Yan et al., 2006).”
BackgroundSelf-citationSastre, M., Dewachter, I., Landreth, G. E., Willson, T. M., Klockgether, T., van Leuven, F., & Heneka, M. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-30-09796.2003 · Cited by 357
Microglial Activation Resulting from CD40-CD40L Interaction After β-Amyloid Stimulation
Tan, J., Town, T., Paris, D., Mori, T., Suo, Z., Crawford, F., Mattson, M. P., Flavell, R. A., & Mullan, M. (1999) · Science · doi:10.1126/science.286.5448.2352 · Cited by 352
Clausen, B. H., Lambertsen, K. L., Babcock, A. A., Holm, T. H., Dagnaes-Hansen, F., & Finsen, B. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-46 · Cited by 315
BLASKO, I., MARX, F., STEINER, E., HARTMANN, T., & GRUBECK‐LOEBENSTEIN, B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.63 · Cited by 280
Huang, H.-C., & Jiang, Z.-F. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0960 · Cited by 279
Lyons, A., Downer, E. J., Crotty, S., Nolan, Y. M., Mills, K. H. G., & Lynch, M. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1781-07.2007 · Cited by 258 · cited 2×
“It is well-established that L-4 is associated with the alternative activation of the acrophage/microglia cell population (Colton et al., 2006; ordon, 2003; Lyons et al., 2007).”
BackgroundNair, M. G., Gallagher, I. J., Taylor, M. D., Loke, P., Coulson, P. S., Wilson, R. A., Maizels, R. M., & Allen, J. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.1.385-394.2005 · Cited by 252
Anti-inflammatory Effects of Human Cord Blood Cells in a Rat Model of Stroke
Vendrame, M., Gemma, C., Mesquita, D. D., Collier, L., Bickford, P. C., Sanberg, C. D., Sanberg, P. R., Pennypacker, K. R., & Willing, A. E. (2005) · Stem Cells and Development · doi:10.1089/scd.2005.14.595 · Cited by 251
Ding, D.-C., Shyu, W.-C., Chiang, M.-F., Lin, S.-Z., Chang, Y.-C., Wang, H.-J., Su, C.-Y., & Li, H. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.06.010 · Cited by 204
Pathways by Which Aβ Facilitates Tau Pathology
Blurton-Jones, M., & LaFerla, F. (2006) · Current Alzheimer Research · doi:10.2174/156720506779025242 · Cited by 195
Lee, J. K., Jin, H. K., & Bae, J.-S. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2008.11.059 · Cited by 189
Self-citationThe β-Secretase, BACE: A Prime Drug Target for Alzheimer's Disease
Vassar, R. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:157 · Cited by 186
Zhao, W., Xie, W., Xiao, Q., Beers, D. R., & Appel, S. H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04172.x · Cited by 171
Wiley, C. A., Lopresti, B. J., Venneti, S., Price, J., Klunk, W. E., DeKosky, S. T., & Mathis, C. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.511 · Cited by 163
Koistinaho, M., Ort, M., Cimadevilla, J. M., Vondrous, R., Cordell, B., Koistinaho, J., Bures, J., & Higgins, L. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261562998 · Cited by 160
Microglia, Scavenger Receptors, and the Pathogenesis of Alzheimer’s Disease
El Khoury, J., Hickman, S. E., Thomas, C. A., Loike, J. D., & Silverstein, S. C. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00036-0 · Cited by 159
Falcone, M., Rajan, A. J., Bloom, B. R., & Brosnan, C. F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4822 · Cited by 158
Butovsky, O., Koronyo‐Hamaoui, M., Kunis, G., Ophir, E., Landa, G., Cohen, H., & Schwartz, M. (2006) · Cited by 144
Praticò, D., & Trojanowski, J. Q. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00141-x · Cited by 127
Nikolic, W. V., Hou, H., Town, T., Zhu, Y., Giunta, B. N., Sanberg, C. D., Zeng, J., Luo, D., Ehrhart, J. C., Mori, T., et al. (2008) · Stem Cells and Development · doi:10.1089/scd.2008.0018 · Cited by 124
Kim, D., Kim, J. H., Lee, J. K., Choi, S. J., Kim, J.-S., Jeun, S., Oh, W., Yang, Y. S., & Chang, J. W. (2008) · Stem Cells and Development · doi:10.1089/scd.2008.0050 · Cited by 89
Self-citationCord Blood Stem Cells: A Review of Potential Neurological Applications
Harris, D. T. (2008) · Stem Cell Reviews and Reports · doi:10.1007/s12015-008-9039-8 · Cited by 76
van Groen, T., Kadish, I., Wiesehan, K., Funke, S. A., & Willbold, D. (2008) · ChemMedChem · doi:10.1002/cmdc.200800289 · Cited by 73
Chen, S., Chang, F. M., Tsai, Y. C., Huang, K., Lin, C. L., & Lin, M. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.11.015 · Cited by 53
Prevention and Reduction of AD‐type Pathology in PDAPP Mice Immunized with Aβ1–42
Games, D., Bard, F., Grajeda, H., Guido, T., Khan, K., Soriano, F., Vasquez, N. J., Wehner, N., Johnson‐Wood, K., Yednock, T. A., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06936.x · Cited by 51
Demethylallosamidin, a chitinase inhibitor, suppresses airway inflammation and hyperresponsiveness
Matsumoto, T., Inoue, H., Sato, Y., Kita, Y., Nakano, T., Noda, N., Tsuda, M., Moriwaki, A., Kan‐o, K., Matsumoto, K., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.075 · Cited by 39
Hirko, A. C., Dallasen, R., Jomura, S., & Xu, Y. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0075 · Cited by 35
Cited by
Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy
Fakhoury, M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170720095240 · Cited by 479
Mesenchymal Stem Cells for Neurological Disorders
Andrzejewska, A., Dabrowska, S., Lukomska, B., & Janowski, M. (2021) · Advanced Science · doi:10.1002/advs.202002944 · Cited by 359
Cui, G.-H., Guo, H.-D., Li, H., Zhai, Y., Gong, Z.-B., Wu, J., Liu, J.-S., Dong, Y.-R., Hou, S.-X., & Liu, J.-R. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0150-2 · Cited by 347
Alzheimer’s disease, dementia, and stem cell therapy
Duncan, T., & Valenzuela, M. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0567-5 · Cited by 338
Losurdo, M., Pedrazzoli, M., D'Agostino, C., Elia, C. A., Massenzio, F., Lonati, E., Mauri, M., Rizzi, L., Molteni, L., Bresciani, E., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0327 · Cited by 260
Metadata
- Authors
- Lee, H. J., Lee, J. K., Lee, H., Carter, J. E., Chang, J. W., Oh, W., Yang, Y. S., Suh, J.-G., Lee, B.-H., Jin, H. K., & Bae, J.-S.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 33
- Issue
- 3
- Pages
- 588-602
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2095066614
- Cited by
- 283
- References
- 58
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Ministry of Education, Science and Technology (R32-10064)
- Stem Cell Research Center (SC4170)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.